Evaluation of allergen-microarray–guided dietary intervention as treatment of eosinophilic esophagitis - 06/10/15

| Disclosure of potential conflict of interest: B. J. Vlieg-Boerstra has received consultancy fees from Chef Martin, Lelystad, The Netherlands. R. van Ree's institution has received or has grants pending from the European Union's Framework 7 program. R. van Ree has received consultancy fees from HAL Allergy BV and Bayer CropScience and compensation for delivering lectures from ThermoFisher. A. J. Bredenoord has received consultancy fees, as well as payment for delivering lectures from MMS, has received payment for delivering lectures from AstraZeneca, and has received or has grants pending from MMS and Shire. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 136 - N° 4
P. 1095 - octobre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
